This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Gegerfelt, A. S.
Right arrow Articles by Felber, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Gegerfelt, A. S.
Right arrow Articles by Felber, B. K.

 Previous Article  |  Next Article 

Journal of Virology, February 2007, p. 1972-1979, Vol. 81, No. 4
0022-538X/07/$08.00+0     doi:10.1128/JVI.01990-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Long-Lasting Decrease in Viremia in Macaques Chronically Infected with Simian Immunodeficiency Virus SIVmac251 after Therapeutic DNA Immunization{triangledown}

Agneta S. von Gegerfelt,1 Margherita Rosati,1 Candido Alicea,2 Antonio Valentin,1 Patricia Roth,1 Jenifer Bear,2 Genoveffa Franchini,3 Paul S. Albert,4 Norbert Bischofberger,5 Jean D. Boyer,6 David B. Weiner,6 Phillip Markham,7 Zimra R. Israel,8 John H. Eldridge,8 George N. Pavlakis,1* and Barbara K. Felber2

Human Retrovirus Section,1 Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702,2 Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research,3 Biometric Research Branch, National Cancer Institute, Bethesda, Maryland 20892,4 Gilead Sciences, Foster City, California 94404,5 Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104,6 Advanced BioSciences Laboratories, Inc., Kensington, Maryland 20895,7 Wyeth Vaccines Research, Pearl River, New York 109658

Received 12 September 2006/ Accepted 20 November 2006

Rhesus macaques chronically infected with highly pathogenic simian immunodeficiency virus (SIV) SIVmac251 were treated with antiretroviral drugs and vaccinated with combinations of DNA vectors expressing SIV antigens. Vaccination during therapy increased cellular immune responses. After the animals were released from therapy, the virus levels of 12 immunized animals were significantly lower (P = 0.001) compared to those of 11 animals treated with only antiretroviral drugs. Vaccinated animals showed a persistent increase in immune responses, thus indicating both a virological and an immunological benefit following DNA therapeutic vaccination. Several animals show a long-lasting decrease in viremia, suggesting that therapeutic vaccination may provide an additional benefit to antiretroviral therapy.

* Correspondence author. Mailing address: Human Retroviruses Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, 1050 Boyles Street, Building 535, Room 210, Frederick, MD 21702-1201. Phone: (301) 846-1475. Fax: (301) 846-7146. E-mail: pavlakis{at}ncifcrf.gov.

{triangledown} Published ahead of print on 29 November 2006.

Journal of Virology, February 2007, p. 1972-1979, Vol. 81, No. 4
0022-538X/07/$08.00+0     doi:10.1128/JVI.01990-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Rosati, M., Bergamaschi, C., Valentin, A., Kulkarni, V., Jalah, R., Alicea, C., Patel, V., von Gegerfelt, A. S., Montefiori, D. C., Venzon, D. J., Khan, A. S., Draghia-Akli, R., Van Rompay, K. K. A., Felber, B. K., Pavlakis, G. N. (2009). DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc. Natl. Acad. Sci. USA 106: 15831-15836 [Abstract] [Full Text]  
  • Wang, Y., Blozis, S. A., Lederman, M., Krieg, A., Landay, A., Miller, C. J. (2009). Enhanced Antibody Responses Elicited by a CpG Adjuvant Do Not Improve the Protective Effect of an Aldrithiol-2-Inactivated Simian Immunodeficiency Virus Therapeutic AIDS Vaccine. CVI 16: 499-505 [Abstract] [Full Text]  
  • Halwani, R., Boyer, J. D., Yassine-Diab, B., Haddad, E. K., Robinson, T. M., Kumar, S., Parkinson, R., Wu, L., Sidhu, M. K., Phillipson-Weiner, R., Pavlakis, G. N., Felber, B. K., Lewis, M. G., Shen, A., Siliciano, R. F., Weiner, D. B., Sekaly, R.-P. (2008). Therapeutic Vaccination with Simian Immunodeficiency Virus (SIV)-DNA+IL-12 or IL-15 Induces Distinct CD8 Memory Subsets in SIV-Infected Macaques. J. Immunol. 180: 7969-7979 [Abstract] [Full Text]  
  • De Boer, R. J. (2007). Understanding the Failure of CD8+ T-Cell Vaccination against Simian/Human Immunodeficiency Virus. J. Virol. 81: 2838-2848 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»